Correlates of HIV infection among incarcerated women: Implications for improving detection of HIV infection
- 128 Downloads
The prevalence of HIV infection in correctional settings is several-fold higher than found in community settings. New approaches to identifying HIV infection among prisoners are urgently needed. In order to determine the HIV seroprevalence and to identify the correlates of HIV infection among female prisoners, an anonymous, but linked HIV serosurvey was conducted at Connecticut’s sole correctional facility for women (census=1,100). After removing all individual identifiers for inmates’ standardized clinical and risk behavior information, data are linked by a third source to blinded HIV-testing information by a third party. This three-step sequential process allows for anonymous HIV testing that can still be linked with deidentified clinical and behavioral data. Of the 3,315 subjects with complete information, 250 (7,5%) were HIV+. Of these, 157 (63%) selfreported being HIV+. Using multiple logistic regression analysis, having sex with a known HIV+ person [adjusted odds ratio (AOR)=9.1] and injection drug use (AOR=6.1) were the most highly correlated risk factors for HIV, whereas leukopenia (AOR=9.4) and hypoalbuminemia (AOR=7.2) were the most significant laboratory markers. Other independent correlates of HIV included self-report of syphilis (AOR=1.9) or genital herpes infection (AOR=2.7) and being Black (AOR=2.1) or Hispanic (AOR=2.2). The prevalence of HIV and HIV-risk behaviors is high among incarcerated women. Existing voluntary HIV counseling and testing programs do not completely target high-risk groups who remain part of the evolving epidemic. Defined demographic, behavioral, and clinical assessments may provide useful information for encouraging targeted counseling and testing. Newer targeted approaches merit further study to determine the effectiveness of this approach. Alternative methods of facilitating more widespread HIV testing, such as saliva tests, rapid serologic tests, and more routine testing in high HIV-prevalence areas should be considered both for clinical and for public health benefits.
KeywordsCondoms HIV testing HIV Hypoalbuminemia Injection drug use Prisoners Prostitution Risk behavior Seroprevalence Sexually transmitted diseases Violence Women
Unable to display preview. Download preview PDF.
- 1.Fleming P, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections; February 24–28, 2000; Seattle, Washington. Abstract 11. Available at: http://www.retroconference.org/2002/abstract/13996.htm. Accessed April 4, 2005.Google Scholar
- 2.CDC. Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329–332.Google Scholar
- 7.Maruschak LM. HIV in prisons, 2001. Bureau of justice statistics bulletin Jan 2004. NCJ 202293. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/hivp01.pdf. Accessed January 17, 2004.Google Scholar
- 12.Ramratnam B, Rich JD, Tsoulfas G, et al. Former prisoners’ views on mandatory HIV testing during incarceration. J Investig Med. 1996;44:A251.Google Scholar
- 18.Revised guidelines for HIV counseling, testing and referral and revised recommendations for HIV screening of pregnant women. MMWR Morb Mortal Wkly Rep. 2001;50:1–121.Google Scholar
- 20.Incorporating HIV prevention into the medical care of persons living with HIV. MMWR Morb Mortal Wkly Rep. 2003;52:1–24.Google Scholar
- 21.Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2002. In: HIV/AIDS Surveillance Report. Vol 14. Available at: http://www.cdc.gov/ hiv/stats/hasr1402.htm. Accessed Junuary 17, 2004.Google Scholar
- 32.Centers for Disease Control and Prevention. AIDS associated with injecting-drug use-United States, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:392–397.Google Scholar